We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.
- Authors
Peck, Amy R; Witkiewicz, Agnieszka K; Liu, Chengbao; Stringer, Ginger A; Klimowicz, Alexander C; Pequignot, Edward; Freydin, Boris; Tran, Thai H; Yang, Ning; Rosenberg, Anne L; Hooke, Jeffrey A; Kovatich, Albert J; Nevalainen, Marja T; Shriver, Craig D; Hyslop, Terry; Sauter, Guido; Rimm, David L; Magliocco, Anthony M; Rui, Hallgeir
- Abstract
To investigate nuclear localized and tyrosine phosphorylated Stat5 (Nuc-pYStat5) as a marker of prognosis in node-negative breast cancer and as a predictor of response to antiestrogen therapy.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Vol 29, Issue 18, p2448
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2010.30.3552